Why IMU is a multi multi bagger, page-26351

Hey bud. Since we all like living in the present, a better comparison might be other biotechnology or healthcare companies in the industry. The minimum market cap was $90M I believe and I tried to focus mainly on biotechnology companies, though it was a little more difficult as not every company has released their 2024 annual report. In any case, IMU leads Australia in renumeration - they are actually 2.5x the average for this dataset.



Something that I found interesting was calculating the ratio of renumeration to market cap in $M. This gave a number that reflected the amount of money paid for every $M worth of market cap. Graphing this with Market Cap ($M) reveals a very interesting trend. IMU either need to decrease their spending for a company of their size, or decrease their market cap relative to a renumeration ratio of that magnitude.